抑郁症作为减重手术患者不良结局和医疗资源利用增加的风险因素
密歇根减重手术协作组纳入2017至2022年接受初次Roux-en-Y胃旁路术或袖状胃切除术的44301例患者,按基线PHQ-8评分分层。30.8%存在不同程度抑郁,其中轻度19.8%、中度7.5%、重度3.5%。抑郁与延长住院时间相关,重度抑郁组吸烟、酒精使用障碍、阿片类药物和大麻使用率均显著更高,但并发症、再手术、急诊就诊和再入院无显著差异。
要点
- 30.8%的减重手术患者存在抑郁,其中中度至重度超过10%。
- 重度抑郁组延长住院时间(>3天)发生率3.0%,无抑郁组2.1%,p=0.0452。
- 重度抑郁组吸烟12.5% vs 无抑郁组9.7%,酒精使用障碍14.0% vs 8.6%,阿片类22.4% vs 14.5%,大麻15.5% vs 8.4%。
核心结论
- 近三分之一减重手术患者存在抑郁,超过10%处于中度至重度范围。
- 术前抑郁症状与减重手术后延长住院时间显著相关,并与吸烟、大麻、处方阿片类和酒精使用率更高相关。
- 抑郁对不良事件或其他医疗资源利用指标无显著影响。
研究设计与样本
- 密歇根减重手术协作组是全州质量改进项目,维护大型临床注册数据库。
- 评估2017年至2022年接受初次Roux-en-Y胃旁路术或袖状胃切除术的患者。
- 患者基线自报抑郁症状(PHQ-8)及酒精(AUDIT-C)、吸烟、处方阿片类和大麻使用情况。
- 术前PHQ-8评分分层:无抑郁(0-4)、轻度(5-9)、中度(10-14)、重度(15-24)。
- 比较有无抑郁患者的30天结局和物质使用,共纳入44301例患者。
主要发现
- 44301例患者中30.8%存在某种程度抑郁,轻度19.8%、中度7.5%、重度3.5%。
- 延长住院时间(>3天):无抑郁组2.1% vs 重度抑郁组3.0%,p=0.0452。
- 并发症:无抑郁组5.7% vs 重度抑郁组5.2%,p=0.1564,无显著差异。
- 再手术:无抑郁组0.9% vs 重度抑郁组0.8%,p=0.7394;急诊就诊:7.7% vs 7.8%,p=0.5353;再入院:3.2% vs 3.9%,p=0.3034,均无显著差异。
- 重度抑郁组较无抑郁组:吸烟12.5% vs 9.7%(p<0.0001)、酒精使用障碍14.0% vs 8.6%(p<0.0001)、阿片类使用22.4% vs 14.5%(p<0.0001)、大麻使用15.5% vs 8.4%(p=0.0008)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Depression is strongly associated with obesity and is common among patients undergoing bariatric surgery. Little is known about the impact of depression on early postoperative outcomes or its association with substance use. METHODS: The Michigan Bariatric Surgery Collaborative is a statewide quality improvement program that maintains a large clinical registry. We evaluated patients undergoing primary Roux-en-Y gastric bypass or sleeve gastrectomy between 2017 and 2022. Patients self-reported symptoms of depression (PHQ-8) and use of alcohol (AUDIT-C), smoking, prescription opiates, and marijuana at baseline. Preoperative PHQ-8 scores stratified patients based on severity: no depression (0-4), mild (5-9), moderate (10-14), or severe (15-24). We compared 30-day outcomes and substance use between patients with and without depression. RESULTS: Among 44,301 patients, 30.8% had some level of depression, with 19.8% mild, 7.5% moderate, and 3.5% severe. Patients with depression were more likely to have an extended length of stay (LOS) (> 3 days) than those without depression (no depression 2.1% vs. severe depression 3.0%, p = 0.0452). There were no significant differences between no depression and severe depression groups in rates of complications (5.7% vs. 5.2%, p = 0.1564), reoperations (0.9%, vs. 0.8%, p = 0.7394), ED visits (7.7% vs. 7.8%, p = 0.5353), or readmissions (3.2% vs. 3.9%, p = 0.3034). Patients with severe depression had significantly higher rates of smoking (9.7% vs. 12.5%, p < 0.0001), alcohol use disorder (8.6% vs. 14.0%, p < 0.0001), opiate use (14.5% vs. 22.4%, p < 0.0001) and marijuana use (8.4%, vs. 15.5%, p = 0.0008). CONCLUSIONS: This study demonstrated that nearly one-third of patients undergoing bariatric surgery have depression, with over 10% in the moderate to severe range. There was a significant association between preoperative depressive symptoms and extended LOS after bariatric surgery, as well as higher rates of smoking and use of marijuana, prescription opiates and alcohol. There was no significant effect on adverse events or other measures of healthcare utilization.
引用
- Ramirez JL, Kim E, Fregenal AC, et al. Depression as a risk factor for adverse outcomes and increased healthcare utilization in bariatric surgery patients. Surg Endosc. 2023. PMID: 37735218. doi:10.1007/s00464-023-10353-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。